6 Strategic Pillars For Selecting A Drug Packaging Partner

By Scott Mills and Armando Pedoto, Sr., Adare Pharma Solutions

Choosing the right pharmaceutical packaging partner is as vital as securing a reliable API supply or proving clinical efficacy. Engaging a partner early allows drug OEMs to develop safe, cost-effective strategies from precommercial stages through commercial launch. An ideal partner offers comprehensive capabilities, ensuring specific formulations are managed with expert environmental controls and validated processes. Global infrastructure is equally important, providing the capacity to scale production and maintain sufficient stock against supply shocks.

Furthermore, integrated end-to-end services preserve project continuity throughout the product lifecycle, while deep technical expertise in both traditional and novel dosage forms fosters patient-centric innovation. Operationally, a strong partner maintains rigorous quality systems and a clear track record of regulatory compliance and meeting strict timelines. Finally, a customer-centric culture ensures flexible, collaborative relationships where the partner proactively suggests enhancements to improve manufacturability and performance. Together, these factors transform packaging into a strategic asset for long-term commercial success and patient safety.